Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Estimates of the benefit of adjuvant chemotherapy in responders versus nonresponders after chemoradiotherapy for rectal cancer, from an analysis of five European randomized trials

Estimates of the benefit of adjuvant chemotherapy in responders versus nonresponders after chemoradiotherapy for rectal cancer, from an analysis of five European randomized trials
Estimates at five years Responders (ie, ypT0N0) Nonresponders (ie, ypT3N1)
Adjuvant chemo negative Adjuvant chemo positive Adjuvant chemo negative Adjuvant chemo positive
Local recurrence risk (%) 3 2 20 12
Distant metastasis risk (%) 11 9 51 36
Death (%) 11.5 9.5 68 57
Data from: Valentini V, van Stiphout RG, Lammering G, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 2011; 29:3163.
Graphic 111447 Version 1.0

Do you want to add Medilib to your home screen?